Please login to the form below

Not currently logged in
Email:
Password:

therapy watch

This page shows the latest therapy watch news and features for those working in and with pharma, biotech and healthcare.

New biosimilars group will tackle slow uptake in UK

New biosimilars group will tackle slow uptake in UK

Despite being around for several years in Europe, the awareness of biosimilars remains fairly low - with a survey carried out in 2014 by Therapy Watch finding just 8% of EU physicians

Latest news

  • Creating a brand identity for biosimilars Creating a brand identity for biosimilars

    Only 8 per cent of EU physicians spontaneously mentioned biosimilars as products in development in a recent survey by Therapy Watch, and only 35 per cent said they would definitely consider

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    Deal Watch May 2016. Novartis, Quintiles and Sanofi are among those featured in this month’ s round-up of pharma deal activity. ... 271. Galapagos/ AbbVie. Agreement extension. Cystic fibrosis alliance for development of a triple combination therapy;

  • The evolving biosimilars market The evolving biosimilars market

    Although these key regulatory developments are expected to greatly facilitate the approval of biosimilars in the near future, recent research from Research Partnership's Therapy Watch revealed that only 47% of

  • Pharma deals in April 2015 Pharma deals in April 2015

    Pharma deals in April 2015. The love affair with oncology continues, finds Medius Deal Watch. ... Watch this space! Gene Therapy. After years of promise and failing to deliver, gene therapy companies are back in favour.

  • Biosimilars: friend or foe for healthcare systems? Biosimilars: friend or foe for healthcare systems?

    As the Therapy Watch data indicates, though, many believe the decision will ultimately be taken out of their hands. ... Fleetwood is director of Therapy Watch at the Research Partnership and can be contacted on tel: 44 208 0695049 or email her.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Research Partnership appoints new directors Research Partnership appoints new directors

    th. anniversary.”. “Having worked with Anne previously as a client of our syndicated market-tracking tool Therapy Watch, it’s great to now be able to welcome her to our

  • Helen Parfitt joins Research Partnership Helen Parfitt joins Research Partnership

    Helen Parfitt joins Research Partnership. She takes on role as head of its Therapy Watch market tracking tool. ... I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Therapy Watch market snapshots

    Therapy Watch market snapshots. Therapy Watch is a ‘ real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. ... Run entirely online to ensure

  • News: Therapy Watch HCV expands into 4 additional EU markets

    News: Therapy Watch HCV expands into 4 additional EU markets. The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment

  • Therapy Watch expands oncology and IBD portfolios

    Therapy Watch expands oncology and IBD portfolios. This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new ... Therapy Watch CML is part of a wider oncology

  • AAD conference 2016

    AAD conference 2016. Therapy Watch recently presented “ real-world” patient data on treatment duration and persistence among European PsO patients.

  • Infographic: HIV Market Snapshot

    Infographic: HIV Market Snapshot. Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently ... Therapy Watch HIV patient data is collected

More from PMHub
Approximately 16 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics